Hi all, A few of us are in the BCR situation so here is a helpful (but hard to read) paper on the situation when BCR and PSA comes back > ncbi.nlm.nih.gov/pmc/articl...
I'm not sure what to make of the paper yet, and as there isn't a standard of care the "big" question for me is when to start ADT after primary/secondary treatment failure. Now or a little later?
We know that generally "early and big" is good (which I did after recurrent PSA following initial RALP), but I've also seen some things that suggest waiting a bit longer.
I have low but notable PSA (<.05, 0.15, 0.29, 0.16, 0.29 over the last few months), all after after RALP and adjuvant RT with 18 months of ADT + Zytiga.
Will learn results from from genomic testing and a PSMA PET MRI last week and then meeting with my MO on Wednesday.
Thanks in advance for any insights or reference to research / specialists that may help.
Your PSA is still low. You could wait for a few more PSA results. If you get three rises in a row, then think about ADT. I waited a several months after primary treatment failed to start ADT. That was a long time ago..
I am also in same situation.
Instead of starting hard core ADT I have started estrogen therapy and my PSA has come to <0.009 from 0.300. No side effects except little boobs.
I intend keep using it as long as my PSA remains low. PSMA Pet CT is all clear.
Many people are going this way and the STAMPEDE study has found good results in their Patch part.